Outcomes and clinicopathologic characteristics associated with disseminated tumor cells in bone marrow after neoadjuvant chemotherapy in high-risk early stage breast cancer: the I-SPY SURMOUNT study.
Mark Jesus M MagbanuaLaura van 't VeerAmy S ClarkA Jo ChienJudy C BougheyHyo S HanAnne WallaceHeather BeckwithMinetta C LiuChristina YauE Paul WileytoAndrea OrdonezTulasi I SolankiFeng HsiaoJen Chieh LeeAmrita BasuLamorna Brown SwigartJane PerlmutterAmy L DelsonLauren BayneShannon DelucaStephanie S YeeErica L CarpenterLaura J EssermanJohn W ParkLewis A ChodoshAngela DeMichelePublished in: Breast cancer research and treatment (2023)
DTC-positivity at surgery after NAC was higher in younger patients, those with larger tumors, and those with residual disease at surgery.
Keyphrases
- neoadjuvant chemotherapy
- early stage
- minimally invasive
- bone marrow
- coronary artery bypass
- end stage renal disease
- sentinel lymph node
- newly diagnosed
- ejection fraction
- locally advanced
- chronic kidney disease
- transcription factor
- mesenchymal stem cells
- prognostic factors
- surgical site infection
- type diabetes
- patient reported outcomes
- young adults
- percutaneous coronary intervention
- coronary artery disease
- metabolic syndrome
- radiation therapy
- skeletal muscle
- patient reported
- glycemic control
- childhood cancer